Pharmacovigilance and Drug Safety Software Market is Expected to Reach USD 14.86 billion by 2030; Growing Incidence of Adverse Drug Reactions Driving Demand Says SNS Insider

Published May 24, 2023

Global Pharmacovigilance and Drug Safety Software Market Size was valued at USD 6.83 billion in 2022. The market is expected to grow to USD 14.86 billion by 2030, exhibiting a CAGR of 10.2% over the forecast period of 2023-2030.

In the research report, various factors that encourage the growth of Pharmacovigilance and Drug Safety Software marketplaces have been analyzed during research. It consists of trends, obstacles, and forces that either positively or negatively affect the market. This section also covers the range of numerous market categories and applications that could potentially affect the market in the future. The market research report examines the key strategies used by top industry players to grow their operations in the international market while maintaining a competitive advantage over their rivals.

The market research report offers details on the history and future of the sector. In addition to a market size analysis, the research report also includes information on market drivers, restrictions, and opportunities. The competitive landscape of the main industry rivals and the percentage market share of the top firms are also displayed in the Pharmacovigilance and Drug Safety Software market report.

Get a Sample Report of Pharmacovigilance and Drug Safety Software Market @

COVID-19 Pandemic Impact Analysis

The Pharmacovigilance and Drug Safety Software market report examines the impact of COVID-19 on the market at the global and national levels. This analysis demonstrates that the COVID-19 pandemic and the post-pandemic period had a major impact on both the supply and demand sides of the market.

Key Company Profiles Listed in this Report are: Aris Global, Capgemini, Accenture, Cognizant, IBM, Laboratory Corporation of America Holdings, Oracle, ICON Plc., Parexel International Corporation, IQVIA and Other Players

Market Segmentation Analysis

To provide a precise assessment and taxonomy of the Pharmacovigilance and Drug Safety Software industry, the market research study effectively segments the market based on a number of kinds, applications, industrial verticals, and geographical regions. By examining past and anticipated trends, all of the segments and sub-segments were evaluated, and various market sizes were projected for the forecast period.

Major Segments & Sub-Segments Listed in this report are:

By Functionality

  • Adverse Event Reporting Software
  • Drug Safety Audits Software
  • Issue Tracking Software
  • Fully Integrated Software

By Delivery

  • On-Premise Delivery Mode
  • On-Demand/Cloud-Based

By End-User

  • Pharma and Biotech Companies
  • Contract Research Organizations (CROS)
  • Business Process Outsourcing (BPO) Firms

Regional Outlook

The detailed examination of the restrictions in the Pharmacovigilance and Drug Safety Software market study shows how they differ from the drivers and provides room for tactical planning. It is important to identify the variables that limit market growth so that new strategies can be developed to take advantage of the lucrative opportunities that exist in the rapidly growing sector. The accurate information in the report will help market participants make rational decisions about local growth and investment.

Do you have Any Specific Queries Related to Pharmacovigilance and Drug Safety Software Market Study? Ask Your Query @

Competitive Analysis

The information in this section will assist readers in understanding the major strategies used by leading market players to control the global Pharmacovigilance and Drug Safety Software market. The research report does PORTER, SVOR, and PESTEL analyses and examines the possible implications of microeconomic market variables. Decision-makers now have a clear image of the future of the sector after analyzing internal and external factors that are projected to have an impact on the organization.

Key Questions Answered in the Pharmacovigilance and Drug Safety Software Market Report

  • The research is regularly updated to take into account new technological advancements, features, and industry changes.
  • The research helps market participants identify a few key businesses and appreciate their essential contributions.
  • The market research report’s estimations and estimates examine how several political, social, and economic factors, as well as the health of the market, affect market growth.

Table of Contents

1. Introduction

2. Research Methodology

3. Market Dynamics

4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession on Major Economies

5. Value Chain Analysis

6. Porter’s 5 forces model

7.  PEST Analysis

8. Pharmacovigilance and Drug Safety Software Market Segmentation, By Functionality

9. Pharmacovigilance and Drug Safety Software Market Segmentation, By Delivery

10. Pharmacovigilance and Drug Safety Software Market Segmentation, By End-User

11. Regional Analysis

12.Company Profiles

13.Competitive Landscape


Buy Single User License Pharmacovigilance and Drug Safety Software Market Research Report @

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy

[email protected]

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)